Effects of tripterygium wilfordii polyglycoside tablets on expression of CD4+ /CD8+ and CD4+ CD25+ Treg in elderly patients with relapsing refractory immune thrombocytopenic purpura

Objective To explore the mechanism of tripterygium wilfordii polyglycoside tablets for elderly patients with relapsing refractory immune thrombocytopenic purpura(ITP), and to seek the theoretical basis for Chinese medicine treatment of this disease. Methods The clinical data of 79 patients with relapsing refractory ITP were retrospectively analyzed.According to whether the combined use of tripterygium wilfordii polyglycoside, they were divided into the control group(35 cases) and the observation group(44 cases). The control group was treated with platelet and tranexamic acid, sulfasalazine, sulforaphane sodium, hemagglutinin and other symptomatic hemostasis treatment.The observation group in symptomatic hemostasis support on the basis of treatment with tripterygium wilfordii polyglycoside tablets.The CD4+ /CD8+ ratio and CD4+ CD25+ Treg expression were compared between the two groups. Results The CD4+ /CD8+ ratio, CD4+ CD25+ Treg and platelet count in the control group before treatmentwere (0.96±0.36), (1.21±0.67)%, (13.14±6.92)×109/L, respectively, which of the observation group were (0.92±0.37), (1.19±0.59)%, (11.51±6.21)×109/L, respectively, there were no statistically significant differences between the two groups(all P>0.05). The CD4+ /CD8+ ratios in peripheral blood of the observation group at 2 weeks, 3 weeks and 4 weeks after treatmentwere (1.04±0.56), (1.55±0.34), (1.59±0.41), respectively, there were statistically significant differences between the two groups(t=9.994, 9.797, all P 0.05). There were statistically significant differences in the CD4+ /CD8+ ratio and CD4+ CD25+ Treg expression between the observation group and control group at 4 weeks after treatment(t=8.589, P 0.05), but the symptoms of bleeding of the observation group was lighter at 3 weeks after treatment. Conclusion Tripterygium wilfordii polyglycoside improves the expression of CD4+ /CD8+ and CD4+ CD25+ Treg in peripheral blood of elderly patients with relapsed or refractory ITP.It is an ideal drug for the treatment of relapsed and refractory ITP in the elderly, it is worth further study. Key words: Tripterygium; Purpura, thrombocytopenic, idiopathic; T-Lymphocytes, regulatory; Aged